Abbott, a leader in diabetes tech with one of the biggest lines of continuous glucose monitors, announced this week that it's issuing a voluntary medical device correction for some of its FreeStyle ...

23/01 Le secteur MedTech d'Abbott Laboratories maintient son dynamisme malgré la faiblesse de la nutrition, selon UBS MT 23/01 Abbott Laboratories anticipe une croissance au second semestre portée par ...

Patients are being warned to stop using some glucose monitors made by Abbott Diabetes Care after the company found malfunctioning sensors may be linked to hundreds of adverse events and several deaths ...

When the FDA approved Abbott’s FreeStyle Libre Flash continuous glucose monitoring (CGM) system in September 2017, diabetes advocates hailed the move as long overdue and one that might lead to greater ...

18/12 TANDEM DIABETES CARE, INC. : Truist Securities maintient sa recommandation neutre ZM 18/12 Tandem Diabetes Care, Inc. annonce la disponibilité de l'application mobile Tandem t:slim pour les ...

Malfunctioning glucose trackers made by Abbott Diabetes Care have been linked to more than 700 severe adverse events and seven potential deaths, the Food and Drug Administration (FDA) and Abbott said.

ABBOTT PARK, Ill.--(BUSINESS WIRE)--Abbott présente aujourd’hui de nouvelles données issues de l’étude en vie réelle RELIEF, qui démontrent que l’utilisation du système de mesure en continu du glucose ...

Mary is an associate editor covering technology, culture and everything in between. She recently graduated from the University of North Carolina at Chapel Hill, where she served as an editor at The ...

FreeStyle Libre is a continuous glucose monitoring (CGM) system. It uses a sensor to read and check a person’s glucose levels. People with diabetes can use FreeStyle Libre to help manage the condition ...

Abbott Laboratories ABT recently announced that the FreeStyle Libre 2 system's reimbursement coverage has been expanded by the French health authority to cover individuals using basal insulin as part ...